Section divider

Helping Ivoirians stay healthy since the 1980s.

  • Jhpiego deployed an electronic platform for monitoring HIV-positive patients on antiretroviral therapy (ART) to help track patients and reduce those who are lost to follow-up or who are being treated at multiple health facilities. This platform was deployed in 170 sites across 27 health regions and 59 health districts, with 158,816 clients on ART registered in the platform. About 95% of these patients were retained in care and 94% were virally suppressed, contributing to the country’s UNAIDS 95-95-95 goals.
  • Jhpiego introduced cervical cancer screening for HIV-positive women using visual inspection with acetic acid coupled with immediate treatment (if needed) via cryotherapy. After scaling up this program and successfully handing it over to the government in 2015, Jhpiego began working to introduce the HPV vaccine and HPV self-testing.
  • With the Ministry of Health and Ministry of Education, Jhpiego built the capacity of vaccinators, facilitated the accessibility of vaccinations in schools, and coordinated the introduction of vaccinating 9-year-old girls against HPV in all health districts nationwide.
  • The MOMENTUM Country and Global Leadership project works on integrated health care with eight ministry directorates and programs, 14 regions and 48 districts. The project has improved availability and application of guidelines and training materials on maternal, newborn and child health and family planning and community-based interventions in integrated intervention areas, including maternal and newborn health, family planning and malaria in pregnancy. The project also revitalized national technical working groups on malaria prevention in pregnant women and children 0–5 years and maternal and child health.

Our Work in Côte d’Ivoire

Moving Integrated, Quality Maternal, Newborn and Child Health and Family Planning and Reproductive Health Services to Scale (MOMENTUM) is a suite of projects, funded by the U.S. Agency for International Development, that aims to accelerate reductions in maternal, newborn and child mortality and morbidity in high-burden countries by increasing host country commitment and capacity to provide high-quality, integrated health care. Each of the projects has a specific focus area; together they provide a comprehensive, flexible package of support for countries as they overcome context-specific health challenges towards sustainable development. The five-year, Jhpiego-led MOMENTUM Country and Global Leadership project focuses on: 1) providing targeted technical and capacity development assistance to our missions, partner countries and local organizations; and 2) contributing to global technical leadership and policy dialogue for improved maternal, newborn and child health, voluntary family planning and reproductive health outcomes. Jhpiego’s 12 sub-partners under this project are: Save the Children, Johns Hopkins University International Vaccine Access Center, The Manoff Group, Quicksand, Matchboxology, BAO Systems, Avenir Health, McKinsey and Company, PACT, Institute for Healthcare Improvement, Christian Connections for International Health and Ubora Quality Institute.

RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights and Mann Global Health. RISE is currently active in several countries, including Côte d’Ivoire.

The human papillomavirus (HPV) vaccine is one of the most effective ways to prevent cervical cancer and other HPV-related diseases, yet there is still disproportionate access to it, specifically among girls and adolescents in low- and middle-income countries. The HAPPI Consortium, funded by the Bill & Melinda Gates Foundation, was launched to increase and sustain equity and program quality, and accelerate coverage of HPV vaccination. John Snow, Inc. and HAPPI Consortium partners Jhpiego, the Clinton Health Access Initiative, International Vaccine Access Center and PATH are focusing on enabling evidence-based policy decisions, enhancing and sustaining equity, improving program quality, providing direct technical assistance in selected countries and monitoring, evaluating and learning to build on the evidence base. Specifically, Jhpiego is supporting the HAPPI/HPV Accelerator-Phase 1 Project to facilitate global coordination and provide HPV vaccine support in several countries, including Côte d’Ivoire.

This grant is a follow-up to the Performance Monitoring for Action project, which used a low-cost, rapid-turnaround survey platform to generate data for decision-making in family planning programs. Under this new grant, the Bill & Melinda Gates Foundation is supporting continued use of the platform for additional data collection and local capacity strengthening.